Regulon

Regulon: R-2508

Regulons are regulatory units consisting of a coherently expressed set of genes and the associated regulator(s) whose binding site(s) they share.

Regulon Summary

Regulon summary table displays all associated information related to the specific regulon including the number of genes in the regulon, Hazard ratio, its Regulator, the Transcriptional Program that includes the regulon, Drugs that are associated with members of the regulon, together with mechanism of action and class, and enriched hallmarks of cancer if any.

GenesCox Hazard RatioRegulatorsCausal FlowsTranscriptional ProgramsHallmarks
162.5549217Pr-155Self sufficiency in growth signalInsensitivity to antigrowth signalEvading apoptosisSustained angiogenesisTissue invasion and metastasisTumor-promoting inflammationReprogramming energy metabolismEvading immune detectionLimitless replicative potentialGenome instability and mutation

Regulon Genes

List of genes that are included in the regulon. These genes have similar expression profiles in subset of patients and they share common binding motif for the Regulator of the regulon. Clicking on the gene name will take you to the gene specific page with more details. Please wait while information is collated from several resources after you click.

Entrez IDEnsEMBL IDPreferred NameUniprot ID
5606 ENSG00000034152 MAP2K3 J3QL77
11284 ENSG00000039650 PNKP Q96T60
9820 ENSG00000044090 CUL7 Q14999
5566 ENSG00000072062 PRKACA P17612
5817 ENSG00000073008 PVR A0A0C4DG49
6560 ENSG00000124067 SLC12A4 Q9UP95
54795 ENSG00000130529 TRPM4 Q8TD43
5371 ENSG00000140464 PML P29590
5045 ENSG00000140564 FURIN P09958
1969 ENSG00000142627 EPHA2 P29317
4000 ENSG00000160789 LMNA P02545
4665 ENSG00000166886 NAB2 Q15742
23612 ENSG00000174307 PHLDA3 Q9Y5J5
977 ENSG00000177697 CD151 A0A024RCB3
51232 ENSG00000277354 CRIM1 Q53TH9
22904 ENSG00000278788 SBNO2 Q9Y2G9

Regulon Drugs

NameApproved SymbolTypeAction TypeMechanism of ActionMax Trial PhaseMax GBM Phase
DASATINIBABL1Small moleculeINHIBITORPlatelet-derived growth factor receptor beta inhibitor42
VANDETANIBEPHA2Small moleculeINHIBITORTyrosine-protein kinase SRC inhibitor42
REGORAFENIBKDRSmall moleculeINHIBITORTyrosine-protein kinase TIE-2 inhibitor42
GSK-690693PRKACBSmall moleculeINHIBITORProtein kinase C (PKC) inhibitor10

Causal Flows

Causal Flows are statistically significant links between putative causal events (somatic mutations, copy number variations, chromosomal translocations, etc.) and the activity levels of regulators and regulons. In the causal flow a mutation may causally activates or deactivates a downstream regulator which then might up- or down-regulates a regulon that contains genes with similar expression profiles and binding sites.

Causal Mechanistic Flows for Regulon R-2508

IDMutationRoleRegulatorRoleRegulon# downstream regulons# diffexp regulonsDrugs
CMF-00364COL6A3up-regulatesPLAG1activatesR-250854Drugs (4)

Regulator Drugs (0)

Regulon Drugs (4)

DASATINIB, VANDETANIB, REGORAFENIB, GSK-690693

CMF-01154ZNF292down-regulatesPLAG1activatesR-250852Drugs (4)

Regulator Drugs (0)

Regulon Drugs (4)

DASATINIB, VANDETANIB, REGORAFENIB, GSK-690693

CMF-12376GPR98down-regulatesPLAG1activatesR-250853Drugs (4)

Regulator Drugs (0)

Regulon Drugs (4)

DASATINIB, VANDETANIB, REGORAFENIB, GSK-690693

CMF-17686MRPL32down-regulatesPLAG1activatesR-250851Drugs (4)

Regulator Drugs (0)

Regulon Drugs (4)

DASATINIB, VANDETANIB, REGORAFENIB, GSK-690693

CMF-19597NF1up-regulatesPLAG1activatesR-250854Drugs (4)

Regulator Drugs (0)

Regulon Drugs (4)

DASATINIB, VANDETANIB, REGORAFENIB, GSK-690693

CMF-28455MYO9Bdown-regulatesPLAG1activatesR-250854Drugs (4)

Regulator Drugs (0)

Regulon Drugs (4)

DASATINIB, VANDETANIB, REGORAFENIB, GSK-690693

CMF-29138FOLH1Bdown-regulatesPLAG1activatesR-250852Drugs (4)

Regulator Drugs (0)

Regulon Drugs (4)

DASATINIB, VANDETANIB, REGORAFENIB, GSK-690693